Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Sepriano

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Annals of the Rheumatic Diseases|February 15, 2025
The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial SpondyloarthritisDenis Poddubnyy, Victoria Navarro-Compán, Murat Torgutalp, et al.
Acta Reumatologica Portuguesa|September 13, 2017
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 updatePedro Machado, Marcos Cerqueira, Pedro Ávila-Ribeiro, et al.
Annals of the Rheumatic Diseases|May 30, 2025
EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgiaHanna W van Steenbergen, Frank Doornkamp, Stefano Alivernini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 9, 2025
EULAR/American College of Rheumatology Risk Stratification Criteria for Development of Rheumatoid Arthritis in the Risk Stage of ArthralgiaHanna W van Steenbergen, Frank Doornkamp, Stefano Alivernini, et al.
Acta Reumatologica Portuguesa|May 24, 2017
Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 updateAna Catarina Duarte, Daniela Santos-Faria, Maria João Gonçalves, et al.
Acta Reumatologica Portuguesa|May 10, 2014
The Portuguese Society of Rheumatology position paper on the use of biosimilarsJoão Eurico Fonseca, João Gonçalves, Filipe Araújo, et al.
Acta Reumatologica Portuguesa|July 12, 2012
2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritisPedro Machado, Mónica Bogas, Ana Ribeiro, et al.
Acta Reumatologica Portuguesa|May 24, 2017
Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis- 2016 updateCatia Duarte, Joana Sousa-Neves, Ana Águeda, et al.
ARP Rheumatology|May 28, 2022
Portuguese recommendations for the use of biological and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis - 2020 updateBruno Miguel Fernandes, Francisca Guimarães, Diogo Esperança Almeida, et al.
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Annals of the Rheumatic Diseases|February 15, 2025
The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial SpondyloarthritisDenis Poddubnyy, Victoria Navarro-Compán, Murat Torgutalp, et al.
Acta Reumatologica Portuguesa|September 13, 2017
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 updatePedro Machado, Marcos Cerqueira, Pedro Ávila-Ribeiro, et al.
Annals of the Rheumatic Diseases|May 30, 2025
EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgiaHanna W van Steenbergen, Frank Doornkamp, Stefano Alivernini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 9, 2025
EULAR/American College of Rheumatology Risk Stratification Criteria for Development of Rheumatoid Arthritis in the Risk Stage of ArthralgiaHanna W van Steenbergen, Frank Doornkamp, Stefano Alivernini, et al.
Acta Reumatologica Portuguesa|May 24, 2017
Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 updateAna Catarina Duarte, Daniela Santos-Faria, Maria João Gonçalves, et al.
Acta Reumatologica Portuguesa|May 10, 2014
The Portuguese Society of Rheumatology position paper on the use of biosimilarsJoão Eurico Fonseca, João Gonçalves, Filipe Araújo, et al.
Acta Reumatologica Portuguesa|July 12, 2012
2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritisPedro Machado, Mónica Bogas, Ana Ribeiro, et al.
Acta Reumatologica Portuguesa|May 24, 2017
Portuguese Recommendations for the use of biological therapies in patients with rheumatoid arthritis- 2016 updateCatia Duarte, Joana Sousa-Neves, Ana Águeda, et al.
ARP Rheumatology|May 28, 2022
Portuguese recommendations for the use of biological and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis - 2020 updateBruno Miguel Fernandes, Francisca Guimarães, Diogo Esperança Almeida, et al.
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Pageof 13